🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to evaluate the efficacy and safety o...
Status
Completed
Location
Phoenix Children's Hospital
Start Date
2018-03-20
Trial ID
NCT03429543
Treatments Being Tested
The current study aims to explore the clinical effects and mechanistics of ...
Status
Unknown
Location
VU University Medical Center
Start Date
2017-11-09
Trial ID
NCT03433248
Treatments Being Tested
This study will test the effect of four common oral anti-diabetic agents on...
Status
Unknown
Location
Oslo University Hospital, Aker Hospital
Start Date
2021-02-10
Trial ID
NCT04662866
Three SGLT2i were commercially available in Italy at the time the trial was...
Status
Unknown
Location
Multiple Locations
Start Date
2021-06-30
Trial ID
NCT04796428
Treatments Being Tested
To compare and evaluate the oral bioavailability of Empagliflozin + Linagli...
Status
Completed
Location
Veeda Clinical Research Ltd.
Start Date
2025-03-08
Trial ID
NCT07039890
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Madalen...
Status
Recruiting
Location
EMS
Start Date
2024-11-18
Trial ID
NCT04670666
The goal of this clinical trial is - Comparison of Empagliflozin - Linaglip...
Status
Completed
Location
Bahria University
Start Date
2022-12-01
Trial ID
NCT07247656
Treatments Being Tested
Diabetes mellitus is a wide-spread disease accompanied by strongly increase...
Status
Completed
Location
Clinical Research Center, Dept of Nephrology and Hypertenison, University of Erlangen/Nürnberg
Start Date
2016-04
Trial ID
NCT02752113
Treatments Being Tested
Glycemic Variability of Combination Therapies in T2DM...
Status
Recruiting
Location
The Catholic University of Korea, Bucheon St. Mary's Hospital, Principal Investigator
Start Date
2025-10-29
Trial ID
NCT07442006
Treatments Being Tested
The objective of the study is to investigate the efficacy, safety and toler...
Status
Completed
Location
1275.10.01019 Boehringer Ingelheim Investigational Site
Start Date
2013-01
Trial ID
NCT01778049